Los Angeles Capital Management LLC Relay Therapeutics, Inc. Transaction History
Los Angeles Capital Management LLC
- $27.9 Billion
- Q2 2024
A detailed history of Los Angeles Capital Management LLC transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 106,169 shares of RLAY stock, worth $694,345. This represents 0.0% of its overall portfolio holdings.
Number of Shares
106,169
Previous 13,939
661.67%
Holding current value
$694,345
Previous $115,000
501.74%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding RLAY
# of Institutions
183Shares Held
127MCall Options Held
1.7KPut Options Held
18K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$182 Million1.68% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$76.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$68.9 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY8.45MShares$55.3 Million4.77% of portfolio
-
Bellevue Group Ag Kuesnacht, V86.38MShares$41.7 Million0.7% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $786M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...